Cardiovascular risk markers (computed tomography‑coronary artery calcium and carotid intima‑media thickness) in patients with rheumatoid arthritis and controls

Fatima,Jalees; Shukla,Vaibhav; Siddiqi,Zeba; Shamsi,Mohammad Zakariya; Mateen,Saboor; Jabbar,Aaliya Abdul; Usmani,Zeenat

doi:10.3892/mi.2024.176

Cardiovascular risk markers (computed tomography‑coronary artery calcium and carotid intima‑media thickness) in patients with rheumatoid arthritis and controls

Authors:
- Jalees Fatima
- Vaibhav Shukla
- Zeba Siddiqi
- Mohammad Zakariya Shamsi
- Saboor Mateen
- Aaliya Abdul Jabbar
- Zeenat Usmani
View Affiliations

Affiliations: Department of Medicine, Era's Lucknow Medical College and Hospital, Lucknow, Uttar Pradesh 226003, India, Department of Cardiology, Mahatma Gandhi Medical College and Hospital, Jaipur, Rajasthan 302022, India
Published online on: July 12, 2024 https://doi.org/10.3892/mi.2024.176
Article Number: 52
Copyright : © Fatima et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Chronic inflammatory diseases, such as arthritis have been linked to a higher risk of developing cardiovascular disease. The present study examined the association between carotid intima‑media thickness (CIMT) and coronary artery calcium (CAC), as well as the cardiovascular risk in patients with rheumatoid arthritis (RA). Additionally, the present study used 28 measures to calculate the disease activity score (DAS). To compare healthy controls with patients with RA, a case‑control study was conducted that assessed CAC and CIMT in patients with the disease. A total of 45 healthy individuals and 45 patients with a diagnosis of RA were included in the study. With an average age of 50.66±12.35 years, the ages of the participants varied from 24 to 80 years. In both the control and RA patient groups, the sex ratio was 60%. The RA patient group had 53.3% female participants. There were significant variations in the levels of serum urea, potassium, magnesium, serum alkaline phosphatase, serum glutamic pyruvic transaminase, total leucocyte count, erythrocyte sedimentation rate, C‑reactive protein (CRP) and lipids [apart from triglycerides and very low‑density lipoprotein (VLDL)]. There was a substantial difference in the scores between patients with RA and the controls as regards CAC. A mild‑severe risk of coronary artery disease was observed in 55.6% of RA cases and 4.4% of the controls (all mild). Both CIMT thickness and the CAC score exhibited a significant correlation with CRP, serum cholesterol, serum triglycerides, serum low‑density lipids and serum VLDL. The DAS of patients ranged between 4.4 and 8.2 (mean, 5.81±0.91). A moderate disease activity was noted in the remaining patients, whereas 66.7% exhibited a high disease activity (DAS >5.2). On the whole, the present study demonstrates that conventional risk factors for cardiovascular disease, such as dyslipidemia, are consistent with both CIMT and CAC. The risk of developing atherosclerosis may be substantially increased by chronic inflammation, as the DAS score corresponds with CIMT and CAC.

View Figures

View References

1	Mohsin Z, Asghar AA, Faiq A, Khalid I, Ul-Haque I, Rehman S, Ahmed SI, Basalat ST, Aimen A, Shafique S, et al: Prevalence of rheumatic diseases in a tertiary care hospital of Karachi. Cureus. 10(e2858)2018.PubMed/NCBI View Article : Google Scholar
2	Shi Y, Wu Y, Ren Y, Jiang Y and Chen Y: Infection risks of rituximab versus non-rituximab treatment for rheumatoid arthritis: A systematic review and meta-analysis. Int J Rheum Dis. 22:1361–1370. 2019.PubMed/NCBI View Article : Google Scholar
3	Okada Y, Eyre S, Suzuki A, Kochi Y and Yamamoto K: Genetics of rheumatoid arthritis: 2018 status. Ann Rheum Dis. 78:446–453. 2019.PubMed/NCBI View Article : Google Scholar
4	Smolen JS, Aletaha D, Koeller M, Weisman MH and Emery P: New therapies for treatment of rheumatoid arthritis. Lancet. 370:1861–1874. 2007.PubMed/NCBI View Article : Google Scholar
5	Rossini M, Rossi E, Bernardi D, Viapiana O, Gatti D, Idolazzi L, Caimmi C, Derosa M and Adami S: Prevalence and incidence of rheumatoid arthritis in Italy. Rheumatol Int. 34:659–664. 2014.PubMed/NCBI View Article : Google Scholar
6	Biver E, Beague V, Verloop D, Mollet D, Lajugie D, Baudens G, Neirinck P and Flipo RM: Low and stable prevalence of rheumatoid arthritis in northern France. Joint Bone Spine. 76:497–500. 2009.PubMed/NCBI View Article : Google Scholar
7	Englund M, Jöud A, Geborek P, Felson DT, Jacobsson LT and Petersson IF: Prevalence and incidence of rheumatoid arthritis in southern Sweden 2008 and their relation to prescribed biologics. Rheumatology (Oxford). 49:1563–1569. 2010.PubMed/NCBI View Article : Google Scholar
8	Hense S, Ramos AL, Callhoff J, Albrecht K, Zink A and Hoffmann F: Prevalence of rheumatoid arthritis in Germany based on health insurance data: Regional differences and first results of the PROCLAIR study. Z Rheumatol. 75:819–827. 2016.PubMed/NCBI View Article : Google Scholar : (In German).
9	Hunter TM, Boytsov NN, Zhang X, Schroeder K, Michaud K and Araujo AB: Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004-2014. Rheumatol Int. 37:1551–1557. 2017.PubMed/NCBI View Article : Google Scholar
10	Jean S, Hudson M, Gamache P, Bessette L, Fortin PR, Boire G and Bernatsky S: Temporal trends in prevalence, incidence, and mortality for rheumatoid arthritis in Quebec, Canada: A population-based study. Clin Rheumatol. 36:2667–2671. 2017.PubMed/NCBI View Article : Google Scholar
11	Bernatsky S, Dekis A, Hudson M, Pineau CA, Boire G, Fortin PR, Bessette L, Jean S, Chetaille AL, Belisle P, et al: Rheumatoid arthritis prevalence in Quebec. BMC Res Notes. 7(937)2014.PubMed/NCBI View Article : Google Scholar
12	Demer LL and Tintut Y: Vascular calcification: Pathobiology of a multifaceted disease. Circulation. 117:2938–2948. 2008.PubMed/NCBI View Article : Google Scholar
13	Oei HH, Vliegenthart R, Hak AE, del Sol A, Hofman A, Oudkerk M and Witteman JC: The association between coronary calcification assessed by electron beam computed tomography and measures of extracoronary atherosclerosis: The rotterdam coronary calcification study. J Am Coll Cardiol. 39:1745–1751. 2002.PubMed/NCBI View Article : Google Scholar
14	Hoffmann U, Massaro JM, Fox CS, Manders E and O'Donnell CJ: Defining normal distributions of coronary artery calcium in women and men (from the Framingham Heart Study). Am J Cardiol. 102:1136–1141. 2008.PubMed/NCBI View Article : Google Scholar
15	Yadav A, Mala M, Yadav GAM and Kumar LN: Effect of cigarette smoking on blood levels of lipid and atherogenic lipid ratios. Natl J Lab Med. 9:1–3. 2020.
16	Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, et al: 2010 rheumatoid arthritis classification criteria: An American college of rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum. 62:2569–2581. 2010.PubMed/NCBI View Article : Google Scholar
17	Kumar BS, Suneetha P, Mohan A, Kumar DP and Sarma KVS: Comparison of disease activity score in 28 joints with ESR (DAS28), clinical disease activity index (CDAI), health assessment questionnaire disability index (HAQ-DI) & routine assessment of patient index data with 3 measures (RAPID3) for assessing disease activity in patients with rheumatoid arthritis at initial presentation. Indian J Med Res. 146:S57–S62. 2017.PubMed/NCBI View Article : Google Scholar
18	Solomon DH, Goodson NJ, Katz JN, Weinblatt ME, Avorn J, Setoguchi S, Canning C and Schneeweiss S: Patterns of cardiovascular risk in rheumatoid arthritis. Ann Rheum Dis. 65:1608–1612. 2006.PubMed/NCBI View Article : Google Scholar
19	Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman KV, Roger VL, Jacobsen SJ and Gabriel SE: Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: A population-based cohort study. Arthritis Rheum. 52:402–411. 2005.PubMed/NCBI View Article : Google Scholar
20	Doran MF, Pond GR, Crowson CS, O'Fallon WM and Gabriel SE: Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum. 46:625–631. 2002.PubMed/NCBI View Article : Google Scholar
21	Riise T, Jacobsen BK and Gran JT: Incidence and prevalence of rheumatoid arthritis in the county of Troms, Northern Norway. J Rheumatol. 27:1386–1389. 2000.PubMed/NCBI
22	Linos A, Worthington JW, O'Fallon WM and Kurland LT: The epidemiology of rheumatoid arthritis in Rochester, Minnesota: A study of incidence, prevalence, and mortality. Am J Epidemiol. 111:87–98. 1980.PubMed/NCBI View Article : Google Scholar
23	Gabriel SE, Crowson CS and O'Fallon WM: The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985. Arthritis Rheum. 42:415–420. 1999.PubMed/NCBI View Article : Google Scholar
24	Schott LL, Kao AH, Cunningham A, Wildman RP, Kuller LH, Sutton-Tyrrell K and Wasko MC: Do carotid artery diameters manifest early evidence of atherosclerosis in women with rheumatoid arthritis? J Womens Health (Larchmt). 18:21–29. 2009.PubMed/NCBI View Article : Google Scholar
25	Targońska-Stepniak B, Drelich-Zbroja A and Majdan M: The relationship between carotid intima-media thickness and the activity of rheumatoid arthritis. J Clin Rheumatol. 17:249–255. 2011.PubMed/NCBI View Article : Google Scholar
26	Udachkina EV, Novikova DS, Popkova TV, Kirillova IG, Markelova EI, Gorbunova YN, Karateev DE, Luchikhina EL, Demidova NV, Borisova MA, et al: Progression of Carotid Artery Atherosclerosis during treatment to target in patients with early rheumatoid arthritis. Rheumatol Sci Pract. 56:449–455. 2018.
27	Sengul I, Akcay-Yalbuzdag S, Ince B, Goksel-Karatepe A and Kaya T: Comparison of the DAS28-CRP and DAS28-ESR in patients with rheumatoid arthritis. Int J Rheum Dis. 18:640–645. 2015.PubMed/NCBI View Article : Google Scholar
28	Emery P: The dunlop-dottridge lecture: Prognosis in inflammatory arthritis: The value of HLA genotyping and the oncological analogy. J Rheumatol. 24:1436–1442. 1997.PubMed/NCBI
29	van Sijl AM, Peters MJ, Knol DL, de Vet RH, Sattar N, Dijkmans BA, Smulders YM and Nurmohamed MT: The effect of TNF-alpha blocking therapy on lipid levels in rheumatoid arthritis: A meta-analysis. Semin Arthritis Rheum. 41:393–400. 2011.PubMed/NCBI View Article : Google Scholar
30	Robertson J, Peters MJ, McInnes IB and Sattar N: Changes in lipid levels with inflammation and therapy in RA: A maturing paradigm. Nat Rev Rheumatol. 9:513–523. 2013.PubMed/NCBI View Article : Google Scholar
31	Charles-Schoeman C, Watanabe J, Lee YY, Furst DE, Amjadi S, Elashoff D, Park G, McMahon M, Paulus HE, Fogelman AM and Reddy ST: Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis. Arthritis Rheum. 60:2870–2879. 2009.PubMed/NCBI View Article : Google Scholar
32	Wahlin B, Meedt T, Jonsson F, Henein MY and Wållberg-Jonsson S: Coronary artery calcification is related to inflammation in rheumatoid arthritis: A long-term follow-up study. Biomed Res Int. 2016(1261582)2016.PubMed/NCBI View Article : Google Scholar
33	Bernardes M, Madureira A, Oliveira A, Martins MJ, Lucas R, Costa L, Pereira JG, Ventura F, Ramos I and Martins E: Coronary artery calcium score in female rheumatoid arthritis patients: Associations with apolipoproteins and disease biomarkers. Int J Rheum Dis. 22:1841–1856. 2019.PubMed/NCBI View Article : Google Scholar